
MedAlliance
MedAlliance is a privately owned company dedicated to developing ground-breaking technology for the treatment of coronary and peripheral arterial disease.
Using breakthrough proprietary technology that combines the proven safety and efficacy of sirolimus with advanced MicroReservoir and Cell Adherent Technology (CAT™).
MedAlliance has found a unique solution to the challenge of controlled and sustained sirolimus release with their SELUTION SLR™ Technology.
www.medalliance.com
Using breakthrough proprietary technology that combines the proven safety and efficacy of sirolimus with advanced MicroReservoir and Cell Adherent Technology (CAT™).
MedAlliance has found a unique solution to the challenge of controlled and sustained sirolimus release with their SELUTION SLR™ Technology.
www.medalliance.com
